Rubinstein Lab OSUCCC – James

The Rubinstein Lab is focused on developing immune-based strategies for the treatment of cancer and human disease.

Research @ UPIKE

Dr. Raphael Pollock, MD – Columbus, OH

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. - Abstract - Europe PMC

Email - The Pelotonia Institute for Immuno-Oncology Spring 2020 Newsletter - Ohio State University Comprehensive Cancer Center

Home rubinsteinlaboratory

Research @ UPIKE

James Rubinstein - Special Education Teacher - Racine Unified School District

Shared Resources OSUCCC – James

Research @ UPIKE

Leading U.S. Cancer Center Selects RayStation for Proton Planning

Claire VERSCHRAEGEN, Director of Medical Oncology, The Ohio State University, OH, OSU, The James Comprehensive Cancer Center

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer

Collaborators — The Paulos Laboratory

Biochemistry, University of Toronto – John L. Rubinstein

Textbook of Complex General Surgical Oncology, PDF, Pancreatic Cancer